Spruce Biosciences separates Harbour BioMed-originated CRHX-101 program into Adrenyx Biosciences
AI Summary- Spruce Biosciences separated the CRHX-101 program into Adrenyx Biosciences.
- Adrenyx Biosciences will advance the Harbour BioMed-originated antibody program.
- CRHX-101 is now being developed through a standalone company.